These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8382913

  • 21. In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas.
    Stefaneanu L, Kovacs K, Horvath E, Lloyd RV, Buchfelder M, Fahlbusch R, Smyth H.
    J Clin Endocrinol Metab; 1994 Jan; 78(1):83-8. PubMed ID: 8288720
    [Abstract] [Full Text] [Related]

  • 22. Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas.
    Asa SL, Ryan N, Kovacs K, Singer W, Marangos PJ.
    Arch Pathol Lab Med; 1984 Jan; 108(1):40-3. PubMed ID: 6362613
    [Abstract] [Full Text] [Related]

  • 23. Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review.
    Sahli R, Christ ER, Seiler R, Kappeler A, Vajtai I.
    Pathol Res Pract; 2006 Jan; 202(6):457-64. PubMed ID: 16497445
    [Abstract] [Full Text] [Related]

  • 24. Expression and mutation analysis of Tpit in the canine pituitary gland and corticotroph adenomas.
    Hanson JM, Mol JA, Leegwater PA, Bilodeau S, Drouin J, Meij BP.
    Domest Anim Endocrinol; 2008 Apr; 34(3):217-22. PubMed ID: 17544240
    [Abstract] [Full Text] [Related]

  • 25. [Immunohistochemical studies of intermediate filament type in the human hypophysis and in adenoma].
    Kasper M.
    Acta Histochem Suppl; 1992 Apr; 42():221-3. PubMed ID: 1374919
    [Abstract] [Full Text] [Related]

  • 26. Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease.
    Akirov A, Larouche V, Shimon I, Asa SL, Mete O, Sawka AM, Gentili F, Ezzat S.
    Front Endocrinol (Lausanne); 2021 Apr; 12():620005. PubMed ID: 33815279
    [Abstract] [Full Text] [Related]

  • 27. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S, Kovacs K, Horvath E, Rotondo F, Kuroki T, Lloyd RV, Scheithauer BW.
    Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
    [Abstract] [Full Text] [Related]

  • 28. Rab3B immunoexpression in human pituitary adenomas.
    Rotondo F, Scheithauer BW, Kovacs K, Bell DC.
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):185-8. PubMed ID: 19384079
    [Abstract] [Full Text] [Related]

  • 29. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A, Sanno N, Tahara S, Osamura YR.
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [Abstract] [Full Text] [Related]

  • 30. Expression of von Hippel-Lindau protein (VHL-P) in nontumorous and adenomatous human pituitaries.
    Vidal S, Stefaneanu L, Kovacs K, Scheithauer BW.
    Pituitary; 1999 May; 1(3-4):227-32. PubMed ID: 11081202
    [Abstract] [Full Text] [Related]

  • 31. Expression of neurotensin and its receptors in pituitary adenomas.
    Giorgi RR, Chile T, Bello AR, Reyes R, Fortes MA, Machado MC, Cescato VA, Musolino NR, Bronstein MD, Giannella-Neto D, Corrêa-Giannella ML.
    J Neuroendocrinol; 2008 Sep; 20(9):1052-7. PubMed ID: 18624930
    [Abstract] [Full Text] [Related]

  • 32. Ganglion cell containing pituitary adenomas: signs of neuronal differentiation in adenoma cells.
    Kontogeorgos G, Mourouti G, Kyrodimou E, Liapi-Avgeri G, Parasi E.
    Acta Neuropathol; 2006 Jul; 112(1):21-8. PubMed ID: 16699777
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Relationship between basic fibroblast growth factor (bFGF) and cell proliferation, invasion in pituitary adenoma].
    Wen L, Chen L, Liu YS.
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct 28; 26(5):466-8. PubMed ID: 12536505
    [Abstract] [Full Text] [Related]

  • 35. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
    Oyama K, Sanno N, Teramoto A, Osamura RY.
    Mod Pathol; 2001 Sep 28; 14(9):892-9. PubMed ID: 11557786
    [Abstract] [Full Text] [Related]

  • 36. Prevalence and clinical characteristics of Crooke's cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review.
    Zhu D, Wang Z, Tian T, Wu X, He D, Zhu Y, Liu D, Wang H.
    Front Endocrinol (Lausanne); 2022 Sep 28; 13():947085. PubMed ID: 36060980
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prognostic indicators in an aggressive pituitary Crooke's cell adenoma.
    Kovacs K, Diep CC, Horvath E, Cusimano M, Smyth H, Lombardero CC, Scheithauer BW, Lloyd RV.
    Can J Neurol Sci; 2005 Nov 28; 32(4):540-5. PubMed ID: 16408589
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.